Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Merck KGaA starts third phase III trial for cancer hope TH-302

Unique method of action to target cells with low oxygen levels

Bristol-Myers Squibb (BMS) building

BMS Q4 results see earnings increase despite fall in sales

Cost-cutting measures at pharma company help overcome patent losses

- PMLiVE

Take-up for Agnitio’s pull marketing platform soars

Closed-loop marketing business sees 50 per cent increase in last two months from healthcare agencies

- PMLiVE

WHO appoints regional director for the Americas

Dominica’s Dr Carissa Etienne has rich history in healthcare policy

- PMLiVE

Making the switch to OTC

Loyalty strategies are much easier to implement in the OTC segment making switching an attractive option for pharma

Emotional connection helps build trust in pharma products

Can be just as important as a product's functional characteristics, according US study

- PMLiVE

Allergan boosts migraine standing with $1bn acquisition

Acquires Californian neurology specialist MAP Pharmaceuticals

- PMLiVE

Amgen profits down on rising costs

R&D and general operating expenses cancel out rise in product sales

- PMLiVE

Roche’s Avastin gains new US colon cancer approval

Patients can continue to use drug once disease progresses

- PMLiVE

Teva suffers setback as Nuvigil fails late-stage trial

Disappointing results in treating bipolar disorder but drug development continues

Novartis building

Novartis expects tough 2013 before a return to growth

Says it will take a year for new medicine sales to overcome Diovan patent loss

- PMLiVE

Bayer’s Jörg Reinhardt to replace Daniel Vasella as Novartis chair

Vasella leaves after 17 years at Swiss pharma company

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links